301033 迈普医学
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.56115.10711.8096.6016.110
总资产报酬率 ROA (%)2.29813.3519.9435.3374.812
投入资产回报率 ROIC (%)2.54015.07011.3355.9445.243

边际利润分析
销售毛利率 (%)78.76680.22879.32782.00684.006
营业利润率 (%)30.32534.70732.94120.90721.176
息税前利润/营业总收入 (%)31.51033.98632.98121.03120.416
净利润/营业总收入 (%)26.43530.67228.32017.70618.302

收益指标分析
经营活动净收益/利润总额(%)88.99090.03881.43785.95364.802
价值变动净收益/利润总额(%)4.6922.4753.8437.68419.982
营业外收支净额/利润总额(%)0.010-1.4561.540-0.511-3.465

偿债能力分析
流动比率 (X)10.9177.2766.5803.9592.914
速动比率 (X)9.6056.5575.8583.5752.554
资产负债率 (%)9.67910.87512.45819.20219.108
带息债务/全部投入资本 (%)-4.988-5.524-7.1342.50510.632
股东权益/带息债务 (%)-1,976.573-1,806.590-1,397.6803,680.851826.510
股东权益/负债合计 (%)933.213819.553702.717420.789423.348
利息保障倍数 (X)26.667-152.539-69.37291.336-398.068

营运能力分析
应收账款周转天数 (天)25.70024.00627.30622.21614.507
存货周转天数 (天)223.128176.099189.112240.943291.585